Ancillary Studies to Ongoing Clinical Projects
Funds short add-on studies riding on an already-running clinical trial, observational study, or patient registry.
This NIH-wide notice pays for a focused add-on study that piggybacks on a clinical project that's already running and already funded — either an interventional clinical trial, an observational study, or a disease-specific registry collecting patient samples and data. The existing project (NIH calls it the “parent project”) supplies the patient cohort, infrastructure, and samples; your ancillary st…
Funding for a focused add-on study — extra data collection, sample analysis, or a sub-study — that rides on an already-running clinical trial, observational study, or patient registry (the “parent project”). The ancillary study itself cannot be a new clinical trial.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
More from NIH
All grants from this funder →GREGoRi Data Coordination and Outreach Center
🇺🇸NIH · United States
Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.
GREGoRi Innovation Projects
NIH · United States
Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.
GREGoRi Technology Integration Center
🇺🇸NIH · United States
Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases
🇺🇸NIH · United States
Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)
🇺🇸NIH · United States
Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01)
NIH · United States
Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.
Similar grants
Browse the directory →
NHMRC Clinical Trials and Cohort Studies Grants
🇦🇺NHMRC · Australia
Funds clinical trials and cohort studies in Australia addressing major evidence gaps in healthcare.
NCATS Preclinical Proof of Concept Studies for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.
INCLUDE Project — Clinical Trials Phased Awards
🇺🇸NICHD · United States
Funds phased clinical research programs for Down syndrome interventions through developmental and expansion awards.
Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
FDA · United States
Funds clinical trials testing whether a product works and is safe for a rare disease, aimed at a new indication or a labeling change.
FFG COMET Projects
🇦🇹FFG · Austria
Supports Austrian academia and firms through collaborative innovation projects that turn research outputs into commercial solutions.
DoW Toxic Exposures Clinical Trial Award
🇺🇸MRDC / CDMRP · United States
Funds one clinical trial, at any scale, testing what helps a disease or condition linked to military-related toxic exposure.